Companies primarily engaged in the research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering. Includes companies specializing in protein-based therapeutics to treat human diseases. Excludes companies manufacturing products using biotechnology but without a health care application.
The Biotechnology industry has on average risen 46.4% over the last 3 months. The average price/earnings ratio is 51.6 and the average return on equity is 110.4%. These averages are based on an equal weighting of the 393 most liquid stocks in this industry.
Symbol | Company Name | Setup | TA | FA | CRS | % Chg | 1 Month | 3 Month | 6 Month | PE | Market Cap | Vol(50) | Action |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 81.79 | -1.12% | 10.04% | 23.58% | 25.11% | 22.09 | 413.22B | 5.37M | ||||
| AMGN | AMGEN INC | 25.82 | 0.16% | 5.02% | -0.12% | 1.19% | 13.66 | 160.37B | 2.35M | ||||
| GILD | GILEAD SCIENCES INC | 77.72 | 1.93% | -2.05% | 0.84% | 5.07% | 14.56 | 139.83B | 6.95M | ||||
| VRTX | VERTEX PHARMACEUTICALS INC | 16.38 | -1.36% | 1.81% | -12.25% | -15.03% | 23.81 | 103.40B | 2.01M | ||||
| REGN | REGENERON PHARMACEUTICALS | 13.59 | 0% | 4.64% | 9.62% | 4.63% | 13.15 | 63.59B | 1.05M | ||||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 91.53 | -1.01% | 0.96% | 37.49% | 93.58% | N/A | 59.82B | 1.22M | ||||
| ARGX | ARGENX SE - ADR | 90.9 | 1.06% | 6.56% | 47.2% | 44.12% | 86.3 | 48.96B | 404.16K | ||||
| ONC | BEONE MEDICINES LTD-ADR | 0 | -0.38% | 0.61% | 40.08% | 44.17% | 6.01 | 40.88B | 342.56K | ||||
| INSM | INSMED INC | 95.4 | 2.85% | 8.31% | 60.7% | 127.18% | N/A | 33.22B | 2.64M | ||||
| BNTX | BIONTECH SE-ADR | 18.76 | 0.94% | -6.2% | -4.1% | 19.81% | N/A | 25.36B | 932.28K | ||||
| BIIB | BIOGEN INC | 49.19 | 2.98% | 13.66% | 20.33% | 30% | 9.99 | 23.44B | 1.68M | ||||
| NTRA | NATERA INC | 76.86 | 4.46% | -0.4% | 3.46% | 25.01% | N/A | 22.97B | 1.30M | ||||
| GMAB | GENMAB A/S -SP ADR | 91.62 | 4.48% | 21.86% | 65.32% | 82.49% | 16.21 | 20.64B | 1.59M | ||||
| UTHR | UNITED THERAPEUTICS CORP | 89.05 | 2.17% | 13.12% | 53.85% | 54.92% | 17.68 | 20.49B | 879.54K | ||||
| INCY | INCYTE CORP | 84.75 | 0.66% | 0.24% | 26.88% | 43.36% | 16.61 | 16.96B | 1.82M | ||||
| SMMT | SUMMIT THERAPEUTICS INC | 34.55 | 2.68% | -17.51% | -12.71% | 23.44% | N/A | 15.92B | 4.01M | ||||
| NBIX | NEUROCRINE BIOSCIENCES INC | 72.98 | 0.21% | -4.91% | 6.13% | 43.26% | 40.54 | 13.59B | 936.40K | ||||
| ASND | ASCENDIS PHARMA A/S - ADR | 85.55 | 1.53% | -0.9% | 17.15% | 43.02% | N/A | 12.34B | 468.82K | ||||
| MRNA | MODERNA INC | 6.9 | 0.42% | 13.33% | -6.56% | 13.46% | N/A | 11.08B | 10.53M | ||||
| ROIV | ROIVANT SCIENCES LTD | 89.91 | 1.19% | 25.15% | 47.13% | 70.93% | N/A | 11.04B | 6.80M |